Wednesday, July 3, 2013
Roche Diagnostics has acquired Boston-based Constitution Medical Investors (CMI). CMI developed a hematology testing system designed to provide faster and more accurate diagnosis of blood-related diseases, which would improve patient care. Roche will pay CMI shareholders $220 million upfront, as well as further contingent payments depending on the achievement of certain milestones. CMI will serve as a center of excellence in the field of hematology within Roche.